Biotech | October 07, 2025
PromoCell launches custom GMP cell culture media to power next-gen cell and gene therapies
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Marks first international filing for Evofem’s single-dose oral treatment
Takeda will seek an external partner to leverage its cell therapy platform technologies
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal phase III IMforte study
Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder for concentrate for solution for infusion is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
The product will be manufactured at Lupin’s Chhatrapati Sambhajinagar facility in India
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
Subscribe To Our Newsletter & Stay Updated
